Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: The effect of seizure type and duration

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages 121-125

  Lehtimaki K A ^a   Keranen T ^a   Huhtala, H ^a   Hurme, M ^a   Ollikainen, J ^a   Honkaniemi, J ^a   Palmio, J ^a   Peltola, J ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

CSF; Cytokine; Epilepsy; GTCS; Partial seizure

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOCAL EPILEPSY; GRAND MAL SEIZURE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEIZURE; TONIC CLONIC SEIZURE;

ANTIGENS, CD; CYTOKINE RECEPTOR GP130; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-6; MEMBRANE GLYCOPROTEINS; RECEPTORS, INTERLEUKIN-6; SEIZURES;

EID: 3042558296     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.01.024     Document Type: Article

References (21)

1. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B., Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. U. S. A. 90:1993;10061-10065
2. D'Arcangelo G., Tancredi V., Onofri F., D'Antuono M., Giovedi S., Benfenati F. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur. J. Neurosci. 12:2000;1241-1252
3. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 12:2000;2623-2633
4. Jankowsky J.L., Derrick B.E., Patterson P.H. Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn. Mem. 7:2000;400-412
5. Jostock T., Mullberg J., Ozbek S., Atreya R., Blinn G., Voltz N., Fischer M., Neurath M.F., Rose-John S. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur. J. Biochem. 268:2001;160-167
6. Lehtimaki K.A., Peltola J., Koskikallio E., Keranen T., Honkaniemi J. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain. Res., Mol. Brain Res. 110:2003;253-260
7. Muller-Newen G., Kuster A., Hemmann U., Keul R., Horsten U., Martens A., Graeve L., Wijdenes J., Heinrich P.C. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol. 161:1998;6347-6355
8. Panegyres P.K., Hughes J. The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. J. Neurol. Sci. 154:1998;123-132
9. Peltola J., Hurme M., Miettinen A., Keranen T. Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures. Epilepsy Res. 31:1998;129-133
10. Peltola J., Palmio J., Korhonen L., Suhonen J., Miettinen A., Hurme M., Lindholm D., Keranen T. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent GTCSs. Epilepsy Res. 41:2000;205-211
11. Peltola J.T., Haapala A., Isojarvi J.I., Auvinen A., Palmio J., Latvala K., Kulmala P., Laine S., Vaarala O., Keranen T. Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders. Am. J. Med. 109:2000;712-717
12. Peltola J., Kulmala P., Isojarvi J., Saiz A., Latvala K., Palmio J., Savola K., Knip M., Keranen T., Graus F. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology. 55:2000;46-50
13. Peltola J., Laaksonen J., Haapala A.M., Hurme M., Rainesalo S., Keranen T. Indicators of inflammation after recent tonic-clonic epileptic seizures correlate with plasma interleukin-6 levels. Seizure. 11:2002;44-46
14. Penkowa M., Molinero A., Carrasco J., Hidalgo J. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience. 102:2001;805-818
15. Penkowa M., Giralt M., Lago N., Camats J., Carrasco J., Hernandez J., Molinero A., Campbell I.L., Hidalgo J. Astrocyte-targeted expression of IL-6 protects the CNS against a focal brain injury. Exp. Neurol. 181:2003;130-148
16. Peters M., Jacobs S., Ehlers M., Vollmer P., Mullberg J., Wolf E., Brem G., Meyer zum Buschenfelde K.H., Rose-John S. The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6. J. Exp. Med. 183:1996;1399-1406
17. Reyes T.M., Fabry Z., Coe C.L. Brain endothelial cell production of a neuroprotective cytokine, interleukin-6, in response to noxious stimuli. Brain Res. 851:1999;215-220
18. Sallmann S., Juttler E., Prinz S., Petersen N., Knopf U., Weiser T., Schwaninger M. Induction of interleukin-6 by depolarization of neurons. J. Neurosci. 20:2000;8637-8642
19. Song C., Lin A., DeJong R., Vandoolaeghe E., Kenis G., Bosmans E., Whelan A., Scharpe S., Maes M. Cytokines in detoxified patients with chronic alcoholism without liver disease: Increased monocytic cytokine production. Biol. Psychiatry. 45:1999;1212-1216
20. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 19:1999;5054-5065
21. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A. 97:2000;11534-11539